Delivery Order SPE2DR25D3301-SPE2DR26F19XC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,460.59 to AmerisourceBergen Drug Corp for DELSTRIGO (100-300-300 mg tablets), a fixed-price pharmaceutical delivery with an ultimate completion date of November 14, 2025. This competitively awarded, non-set-aside order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $43,857.85 to AmerisourceBergen Drug Corp for DELSTRIGO 100-300-300 mg tablets (30-count units) with a firm fixed price structure. The contract was competitively awarded without any set-aside designation and is scheduled for completion by November 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $44,900.61 to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Delstrigo (100-300-300 mg tablets) in quantities of 30 count units. This firm fixed-price delivery order, with an ultimate completion date of May 22, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $5,253.34 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Delstrigo (100-300-300 mg tablets) in a 30-count unit quantity. The contract utilizes firm fixed price pricing with no set-aside designation and is scheduled for completion by May 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a small-value...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DELSTRIGO 100-300-300 MG TAB UU 30S, a specialty pharmaceutical product. The contract has a completion date of January 29, 2024 and a potential value of $17,807.95. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,944,624 units of the pharmaceutical product DELSTRIGO 100-300-300 MG TAB UU 30S. The contract has a firm fixed price of $37,530.36 and a period of performance through April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $10,389.01 from the Defense Logistics Agency (DLA) on November 25, 2025, with completion scheduled for November 26, 2025. The award covers the supply of Dovato 50-300 mg tablets in quantities of 30, a combination antiretroviral medication used in HIV treatment. This delivery order was competitively awarded with no set-aside designation and employs...
- The U.S. government agency's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $8,655.98, is for the delivery of the pharmaceutical product DELSTRIGO 100-300-300 MG TAB UU 30S. This contract does not have a set-aside designation. The award is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,570.02 firm fixed-price delivery order is for the supply of DELSTRIGO 100-300-300 MG TAB UU 30S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,354.64 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19XCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $7,086.70 for DELSTRIGO (a prescription medication for HIV treatment) in tablet form on December 23, 2025, with completion scheduled for December 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contracts demonstrates its capacity to deliver a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty healthcare commodities across multiple therapeutic domains to organizations including the Defense Health Agency and U.S. Coast Guard. This specific delivery order exemplifies the company's role in ensuring continuous pharmaceutical supply to support defense and military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 12/22/25 |